SELLAS Life Sciences Group Inc (SLS)
1.21
-0.25
(-17.12%)
USD |
NASDAQ |
Apr 29, 16:00
1.15
-0.06
(-4.96%)
Pre-Market: 08:51
SELLAS Life Sciences Group Price: 1.21 for April 29, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 29, 2024 | 1.33 | 1.34 | 1.20 | 1.21 | 3.303M |
| Apr 26, 2024 | 1.53 | 1.545 | 1.422 | 1.46 | 1.292M |
| Apr 25, 2024 | 1.52 | 1.58 | 1.50 | 1.52 | 657949.0 |
| Apr 24, 2024 | 1.61 | 1.63 | 1.46 | 1.54 | 1.319M |
| Apr 23, 2024 | 1.54 | 1.72 | 1.46 | 1.63 | 2.037M |
| Apr 22, 2024 | 1.55 | 1.62 | 1.495 | 1.54 | 1.585M |
| Apr 19, 2024 | 1.54 | 1.57 | 1.47 | 1.54 | 1.844M |
| Apr 18, 2024 | 1.46 | 1.53 | 1.40 | 1.52 | 1.598M |
| Apr 17, 2024 | 1.34 | 1.45 | 1.32 | 1.41 | 563827.0 |
| Apr 16, 2024 | 1.32 | 1.41 | 1.28 | 1.36 | 1.210M |
| Apr 15, 2024 | 1.30 | 1.37 | 1.27 | 1.33 | 808484.0 |
| Apr 12, 2024 | 1.42 | 1.42 | 1.30 | 1.34 | 1.110M |
| Apr 11, 2024 | 1.39 | 1.41 | 1.31 | 1.40 | 545748.0 |
| Apr 10, 2024 | 1.38 | 1.48 | 1.33 | 1.39 | 915486.0 |
| Apr 09, 2024 | 1.47 | 1.490 | 1.25 | 1.40 | 2.208M |
| Apr 08, 2024 | 1.38 | 1.49 | 1.36 | 1.445 | 2.297M |
| Apr 05, 2024 | 1.30 | 1.35 | 1.26 | 1.34 | 955624.0 |
| Apr 04, 2024 | 1.32 | 1.36 | 1.26 | 1.29 | 2.030M |
| Apr 03, 2024 | 1.25 | 1.33 | 1.18 | 1.31 | 2.685M |
| Apr 02, 2024 | 1.10 | 1.24 | 1.07 | 1.18 | 2.412M |
| Apr 01, 2024 | 1.03 | 1.08 | 0.975 | 1.07 | 1.631M |
| Mar 28, 2024 | 1.02 | 1.032 | 0.9899 | 1.01 | 1.293M |
| Mar 27, 2024 | 1.02 | 1.06 | 1.00 | 1.03 | 1.129M |
| Mar 26, 2024 | 1.06 | 1.09 | 0.96 | 1.06 | 4.186M |
| Mar 25, 2024 | 1.11 | 1.12 | 1.01 | 1.04 | 2.289M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.506
Minimum
Jan 26 2024
49.80
Maximum
Apr 30 2019
5.080
Average
3.12
Median
Nov 20 2020
Price Benchmarks
| Geron Corp | 4.14 |
| Immuneering Corp | 1.48 |
| Protagonist Therapeutics Inc | 25.56 |
| Akebia Therapeutics Inc | 1.32 |
| Moderna Inc | 111.62 |
Price Related Metrics
| PEG Ratio | -0.0151 |
| Earnings Yield | -112.4% |
| Market Cap | 68.08M |
| PEGY Ratio | -0.0151 |